Future perspectives in melanoma research. Meeting report from the \"Melanoma Bridge. Napoli December 2nd-4th 2012\". (Articolo in rivista)

Type
Label
  • Future perspectives in melanoma research. Meeting report from the \"Melanoma Bridge. Napoli December 2nd-4th 2012\". (Articolo in rivista) (literal)
Anno
  • 2013-01-01T00:00:00+01:00 (literal)
Alternative label
  • Ascierto PA, Grimaldi AM, Acquavella N, Borgognoni L, Calabrò L, Cascinelli N, Cesano A, Del Vecchio M, Eggermont AM, Faries M, Ferrone S, Fox BA, Gajewski TF, Galon J, Gnjatic S, Gogas H, Kashani-Sabet M, Kaufman HL, Larkin J, Lo RS, Mantovani A, Margolin K, Melief C, McArthur G, Palmieri G, Puzanov I, Ribas A, Seliger B, Sosman J, Suenaert P, Tarhini AA, Trinchieri G, Vidal-Vanaclocha F, Wang E, Ciliberto G, Mozzillo N, Marincola FM, Thurin M (2013)
    Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli December 2nd-4th 2012".
    in Journal of translational medicine (Online)
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Ascierto PA, Grimaldi AM, Acquavella N, Borgognoni L, Calabrò L, Cascinelli N, Cesano A, Del Vecchio M, Eggermont AM, Faries M, Ferrone S, Fox BA, Gajewski TF, Galon J, Gnjatic S, Gogas H, Kashani-Sabet M, Kaufman HL, Larkin J, Lo RS, Mantovani A, Margolin K, Melief C, McArthur G, Palmieri G, Puzanov I, Ribas A, Seliger B, Sosman J, Suenaert P, Tarhini AA, Trinchieri G, Vidal-Vanaclocha F, Wang E, Ciliberto G, Mozzillo N, Marincola FM, Thurin M (literal)
Pagina inizio
  • 137 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
  • 11 (literal)
Rivista
Note
  • ISI Web of Science (WOS) (literal)
  • Scopus (literal)
  • PubMed (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • Istituto Nazionale Tumori, Fondazione \"G. Pascale\", Naples, Italy Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MA, USA Plastic and Reconstructive Surgery, Regional Melanoma Refferral Center - S.M. Annunziata Hospital, Florence, Italy Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy WHO Melanoma Program, Milan, Italy Nodality Inc, South San Francisco, USA Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy Cancer Institute Gustave Roussy, Villejuif, Paris-Sud, France John Wayne Cancer Institute, Santa Monica, CA, USA Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA University of Chicago, Chicago, IL, USA INSERM, U872, Laboratory of Integrative Cancer Immunology, Paris F-75006, France Université Paris Descartes, Paris, France Centre de Recherche des Cordeliers, Université Pierre et Marie Curie Paris 6, Paris, France Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA 1st Department of Medicine, Medical School, University of Athens, Athens, Greece Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, CA, USA Rush University, Chicago, IL, USA Royal Marsden NHS Foundation Trust, London, UK Dermatology/Medicine, UCLA Geffen School of Medicine and Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA Humanitas Clinical and Research Institute, Rozzano, Italy Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA Leiden University Medical Center and ISA Pharmaceuticals, Leiden, The Netherlands Peter MacCallum Cancer Centre, East Melbourne, Australia Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy Vanderbilt University Medical Center, Nashville, TN, USA Tumor Immunology Program, Jonsson Comprehensive Cancer Center (JCCC), David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany Vanderbilt-Ingram Comprehensive Cancer Center, Nashville, TN, USA Global Early Clinical Development, Clinical Immunotherapeutics, Immunotherapeutics, GlaxoSmithKline Vaccines, Rixensart, Belgium University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA Cancer and Inflammation Program, Center for Cancer Research, NCI, NIH, Frederick, MD, USA Institute of Applied Molecular Medicine (IMMA), CEU-San Pablo University and HM-Hospitals School of Medicine, Boadilla del Monte, 28668, Madrid, Spain Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Center for Human Immunology (CHI), NIH, Bethesda, MD, USA Sidra Medical and Research Centre, Doha, Qatar Cancer Diagnosis Program. NCI, NIH, Bethesda, MD, USA (literal)
Titolo
  • Future perspectives in melanoma research. Meeting report from the \"Melanoma Bridge. Napoli December 2nd-4th 2012\". (literal)
Prodotto di
Autore CNR

Incoming links:


Prodotto
Autore CNR di
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
data.CNR.it